Do Traders Think ProQR Therapeutics NV (PRQR) Can Keep Climbing Wednesday?

Overall market sentiment has been high on ProQR Therapeutics NV (PRQR) stock lately. PRQR receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

ProQR Therapeutics NV has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRQR!

See Full PRQR Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With PRQR Stock Today?

ProQR Therapeutics NV (PRQR) stock is trading at $2.30 as of 1:36 PM on Wednesday, Mar 13, an increase of $0.25, or 12.15% from the previous closing price of $2.05. The stock has traded between $2.02 and $2.30 so far today. Volume today is 277,198 compared to average volume of 224,576.

More About ProQR Therapeutics NV

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. Click Here to get the full Stock Report for ProQR Therapeutics NV stock.